- Home
- IRMD vs BLFS Comparison
IRMD vs BLFS Comparison
Compare IRMD & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IRMD | BLFS |
|---|---|---|
| Founded | 1992 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2014 | 2013 |
Fundamental Metrics
Financial Performance| Metric | IRMD | BLFS |
|---|---|---|
| Price | $96.08 | $26.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $116.00 | $32.00 |
| AVG Volume (30 Days) | 119.4K | ★ 702.6K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.95% | N/A |
| EPS Growth | 16.67 | ★ 77.27 |
| EPS | ★ 0.45 | 0.02 |
| Revenue | $83,814,000.00 | ★ $96,214,000.00 |
| Revenue This Year | $12.38 | $19.73 |
| Revenue Next Year | $11.31 | $17.82 |
| P/E Ratio | ★ $214.27 | $1,377.50 |
| Revenue Growth | 14.43 | ★ 16.97 |
| 52 Week Low | $55.11 | $17.86 |
| 52 Week High | $107.90 | $29.57 |
Technical Indicators
Market Signals| Indicator | IRMD | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 64.27 | 64.18 |
| Support Level | $96.43 | $26.74 |
| Resistance Level | $97.36 | $28.90 |
| Average True Range (ATR) | 3.30 | 1.33 |
| MACD | 0.72 | 0.12 |
| Stochastic Oscillator | 81.31 | 75.22 |
Price Performance
Historical ComparisonAbout IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.